Showing 421–440 of 650 signals
Regulator·fda.gov·Aug 18, 2026·Other·High materiality
CompaniesEugia Pharma Specialities Limited
Regulator·fda.gov·Aug 18, 2026·Approval·High materiality
CompaniesFDA
Regulator·fda.gov·Aug 18, 2026·Other·Low materiality
Regulator·fda.gov·Aug 18, 2026·Other·High materiality
AssetsEsbelta Chupapanza Flat Belly
Regulator·fda.gov·Aug 18, 2026·Other·High materiality
Regulator·fda.gov·Aug 18, 2026·Other·High materiality
Regulator·fda.gov·Aug 18, 2026·Approval·High materiality
CompaniesJanssen PharmaceuticalsAssetsiberdomidedaratumumabhyaluronidase-fihjdexamethasoneDiseasesmultiple myeloma
Regulator·fda.gov·Aug 18, 2026·Other·Low materiality
Regulator·fda.gov·Aug 4, 2026·Discontinuation·High materiality
CompaniesLiebel-Flarsheim Company, LLCAssetsOPTIRAY Imaging Bulk Package (IBP) 350, 500mL in vialIoversol Injection 74% 350 mg iodine/ml
Regulator·fda.gov·Aug 5, 2026·Discontinuation·High materiality
CompaniesVictory Medical Center PharmacyAssetsCompounded Glutathione 200 mg/mL
Regulator·fda.gov·Aug 5, 2026·Discontinuation·High materiality
CompaniesFresenius KabiAssetsMorphine Sulfate Injection USPMorphine Sulfate Injection, USP, Simplist 2 mg/1 mLDilaudid 0.5 mg/0.5 mL
Regulator·fda.gov·Aug 10, 2026·Discontinuation·High materiality
CompaniesAbiomedOscorAssetsImpella heart pumpsImpella RP Flex with SmartAssist SetImpella RP Set with SmartAssistImpella 5.5 Set with SmartAssistImpella CP SetImpella CP Introducer Kit
Regulator·fda.gov·Aug 11, 2026·Discontinuation·High materiality
CompaniesHamilton MedicalAssetsT1 CIRCUIT 240 +VALVE B/10T1 CIRCUIT 180 +VALVE B/20MR1 CIRCUIT 300 +VALVE B/10MR1 CIRCUIT 480 +VALVE B/8
Regulator·fda.gov·Aug 11, 2026·Discontinuation·High materiality
CompaniesFresenius KabiAssetsTyennetocilizumab-aazgDiseasesrheumatoid arthritisgiant cell arteritispolyarticular juvenile idiopathic arthritissystemic juvenile idiopathic arthritisCAR T cell-induced severe or life-threatening cytokine release syndromeCOVID-19
Regulator·fda.gov·Aug 12, 2026·Discontinuation·High materiality
CompaniesMedlineBecton, Dickinson and CompanyAssetsBD ChloraPrep ApplicatorsBD ChloraPrep Clear - 1 mLFREPP Clear 1.5 mL Applicators
Regulator·fda.gov·Aug 12, 2026·Commercial·Low materiality
CompaniesMedlineICU MedicalHuons Co., Ltd.
Regulator·fda.gov·Aug 13, 2026·Discontinuation·High materiality
CompaniesBaxterAssetsDuo-Vent solution set
Regulator·fda.gov·Aug 17, 2026·Discontinuation·High materiality
CompaniesBecton DickinsonAssetsBD Intraosseous Vascular Access System Needle Sets
Company disclosure·ir.neumoratx.com·Aug 14, 2026·Commercial·Low materiality
CompaniesNeumora Therapeutics
Company disclosure·investors.urogen.com·Aug 5, 2026·Commercial·High materiality
CompaniesUroGen Pharma Ltd.AssetsZUSDURIJELMYTOUGN-103UGN-501Diseaseslow-grade intermediate-risk non-muscle invasive bladder cancerlow-grade upper tract urothelial cancer